(Q43647811)

25 November 2017

0 references

Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk (English)

1 reference

25 November 2017

Lan Wang

1

1 reference

25 November 2017

Rui Gao

series ordinal

2

1 reference

25 November 2017

Long Yu

series ordinal

3

1 reference

25 November 2017

publication date

27 May 2011

1 reference

Molecular Biology Reports

25 November 2017

published in

1 reference

25 November 2017

volume

39

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

1731-1738

1 reference

Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

TP53 family members and human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

p73: a chiaroscuro gene in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Polymorphism of the p73 gene in relation to colorectal cancer risk and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Gene polymorphisms, apoptotic capacity and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Polymorphisms ofp53Arg72Pro,p73G4C14-to-A4T14 at Exon 2 andp21Ser31Arg and the risk of non-Hodgkin's Lymphoma in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0913-0

Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population

21 January 2018

1 reference

12 December 2020

[Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma]

1 reference

12 December 2020

No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population

1 reference

12 December 2020

p73 Overexpression and angiogenesis in human colorectal carcinoma

1 reference

12 December 2020

Association of p53 codon 72 polymorphism with prostate cancer: a meta-analysis

1 reference

12 December 2020

Overexpression of the wild type p73 gene in human bladder cancer

1 reference

12 December 2020

Activation of p73 silent allele in lung cancer.

1 reference

12 December 2020

Overexpression of the wild type p73 gene in breast cancer tissues and cell lines

1 reference

12 December 2020

Combined effects of the p53 and p73 polymorphisms on lung cancer risk

1 reference

12 December 2020

Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.

1 reference

12 December 2020

Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients

1 reference

12 December 2020

Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes.

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

p63 and p73: roles in development and tumor formation

1 reference

12 December 2020

Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours

1 reference

12 December 2020

p73 G4C14-to-A4T14 polymorphism and risk of lung cancer

1 reference

12 December 2020

p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma

1 reference

12 December 2020

Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.

1 reference

12 December 2020

10.1007/S11033-011-0913-0

Identifiers

DOI

1 reference

25 November 2017

1 reference